Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation

Department of Cardiovascular Medicine, Prince Henry Hospital, Sydney, New South Wales, Australia.

OBJECTIVES. This study examined the influence of left atrial spontaneous echo contrast on the subsequent stroke or embolic event rate and on survival in patients with nonvalvular atrial fibrillation. BACKGROUND. Left atrial spontaneous echo contrast is associated with atrial fibrillation and a history of previous stroke or other embolic events. However, the prognostic implications of spontaneous contrast in patients with nonvalvular atrial fibrillation are unknown. METHOD. The study group comprised 272 consecutive patients with nonvalvular atrial fibrillation undergoing transesophageal echocardiography. Clinical and echocardiographic data were collected at baseline, and patients were prospectively followed up, and all strokes, other embolic events and deaths were documented. The relation between spontaneous contrast at baseline and subsequent stroke, other embolic events and survival was analyzed. RESULTS. Left atrial spontaneous echo contrast was detected at baseline in 161 patients (59%). The mean follow-up was 17.5 months. The stroke or other embolic event rate was 12%/year (15 strokes, 3 transient ischemic attacks, 2 peripheral embolisms) in patients with, compared with 3%/year (5 strokes) in patients without, baseline spontaneous contrast (p = 0.002). In 149 patients without previous thromboembolism, the event rate was 9.5%/year in patients with and 2.2%/year in patients without spontaneous contrast (p = 0.003). There were 25 deaths in patients with and 11 deaths in patients without spontaneous contrast. Patients with spontaneous contrast had significantly reduced survival (p = 0.025). On multivariate analysis, spontaneous contrast was the only positive predictor (odds ratio 3.5, p = 0.03) and warfarin therapy on follow-up the only negative predictor (odds ratio 0.23, p = 0.02) of subsequent stroke or other embolic events. CONCLUSIONS. Transesophageal echocardiography can risk stratify patients with nonvalvular atrial fibrillation by identifying left atrial spontaneous echo contrast. These patients have both a significantly higher risk of developing stroke or other embolic events and a reduced survival, and they may represent a subgroup in whom the risk/benefit ratio of anticoagulation may be most favorable.

This article has been cited by other articles:

				Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF]

				V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF]

				V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF]

				R. P. Ward, C. W. Don, K. T. Furlong, and R. M. Lang Predictors of Long-Term Mortality in Patients With Ischemic Stroke Referred for Transesophageal Echocardiography Stroke, January 1, 2006; 37(1): 204 - 208. [Abstract] [Full Text] [PDF]

				A. D. Demir, M. Soylu, O. Ozdemir, S. Topaloglu, D. Aras, A. Iasmaz, and I. Korkmaz Do Different Atrial Flutter Types Carry the Same Thromboembolic Risk? Angiology, September 1, 2005; 56(5): 593 - 599. [Abstract] [PDF]

				P. Bernhardt, H. Schmidt, C. Hammerstingl, B. Luderitz, and H. Omran Patients With Atrial Fibrillation and Dense Spontaneous Echo Contrast at High Risk: A Prospective and Serial Follow-Up Over 12 Months With Transesophageal Echocardiography and Cerebral Magnetic Resonance Imaging J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1807 - 1812. [Abstract] [Full Text] [PDF]

				G Y H Lip, L A Pearce, B S P Chin, D S G Conway, and R G Hart Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation Heart, June 1, 2005; 91(6): 759 - 763. [Abstract] [Full Text] [PDF]

				P. P Sengupta and B. K Khandheria Transoesophageal echocardiography Heart, April 1, 2005; 91(4): 541 - 547. [Full Text] [PDF]

				G Corrado, S Beretta, L Sormani, G Tadeo, G Foglia-Manzillo, L.M Tagliagambe, and M Santarone Prevalence of atrial thrombi in patients with atrial fibrillation/flutter and subtherapeutic anticoagulation prior to cardioversion Eur J Echocardiogr, August 1, 2004; 5(4): 257 - 261. [Abstract] [Full Text] [PDF]

				R. L. McNamara, L. J. Tamariz, J. B. Segal, and E. B. Bass Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography Ann Intern Med, December 16, 2003; 139(12): 1018 - 1033. [Abstract] [Full Text] [PDF]

				R. Castello and T. G. Brott Patent foramen ovale: friend or foe? J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1073 - 1075. [Full Text] [PDF]

				D. S.G. Conway, L. A. Pearce, B. S.P. Chin, R. G. Hart, and G. Y.H. Lip Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation Circulation, July 1, 2003; 107(25): 3141 - 3145. [Abstract] [Full Text] [PDF]

				R. Rastegar, D. J. Harnick, P. Weidemann, V. Fuster, B. Coller, J. J. Badimon, J. Chesebro, and M. E. Goldman Spontaneous echo contrast videodensity isflow-related and is dependent on the relative concentrations of fibrinogen and red blood cells J. Am. Coll. Cardiol., February 19, 2003; 41(4): 603 - 610. [Abstract] [Full Text] [PDF]

				S Illien, S Maroto-Jarvinen, G von der Recke, C Hammerstingl, H Schmidt, S Kuntz-Hehner, B Luderitz, and H Omran Atrial fibrillation: relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism Heart, February 1, 2003; 89(2): 165 - 168. [Abstract] [Full Text] [PDF]

				Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923. [PDF]

				V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266. [Full Text] [PDF]

				N. Shinokawa, T. Hirai, S. Takashima, T. Kameyama, K. Nakagawa, H. Asanoi, and H. Inoue A Transesophageal Echocardiographic Study on Risk Factors for Stroke in Elderly Patients With Atrial Fibrillation : A Comparison With Younger Patients Chest, September 1, 2001; 120(3): 840 - 846. [Abstract] [Full Text] [PDF]

				G Corrado, A Sgalambro, A Mantero, F Gentile, M Gasparini, R Bufalino, A Morabito, G Trocino, R Schiavina, S Mandorla, et al. Thromboembolic risk in atrial flutter. The FLASIEC (FLutterAtrialeSocietaIaliana diEcografiaCardiovascolare) multicentre study Eur. Heart J., June 2, 2001; 22(12): 1042 - 1051. [Abstract] [PDF]

				A. L. Klein, R. D. Murray, and R. A. Grimm Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation J. Am. Coll. Cardiol., March 1, 2001; 37(3): 691 - 704. [Abstract] [Full Text] [PDF]

				A Roijer, J Eskilsson, and B Olsson Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion Eur. Heart J., May 2, 2000; 21(10): 837 - 847. [Abstract] [PDF]

				L.-M. Tsai, T.-H. Chao, and J.-H. Chen Association of Follow-up Change of Left Atrial Appendage Blood Flow Velocity With Spontaneous Echo Contrast in Nonrheumatic Atrial Fibrillation Chest, February 1, 2000; 117(2): 309 - 313. [Abstract] [Full Text] [PDF]

				N M Al-Saady, O A Obel, and A J Camm Left atrial appendage: structure, function, and role in thromboembolism Heart, November 1, 1999; 82(5): 547 - 554. [Abstract] [Full Text]

				J. L. Blackshear, L. A. Pearce, R. G. Hart, M. Zabalgoitia, A. Labovitz, R. W. Asinger, and J. L. Halperin Aortic Plaque in Atrial Fibrillation : Prevalence, Predictors, and Thromboembolic Implications Stroke, April 1, 1999; 30(4): 834 - 840. [Abstract] [Full Text] [PDF]

				H Omran, W Jung, R Rabahieh, P Wirtz, H Becher, S Illien, R Schimpf, and B Lüderitz Imaging of thrombi and assessment of left atrial appendage function: a prospective study comparing transthoracic and transoesophageal echocardiography Heart, February 1, 1999; 81(2): 192 - 198. [Abstract] [Full Text]

				B. Censori, F. Colombo, M. G. Valsecchi, L. Clivati, A. Zonca, M. Camerlingo, L. Casto, M. S. De Tommasi, and A. Mamoli Early transoesophageal echocardiography in cryptogenic and lacunar stroke and transient ischaemic attack J. Neurol. Neurosurg. Psychiatry, May 1, 1998; 64(5): 624 - 627. [Abstract] [Full Text] [PDF]

				M. D. Cheitlin, J. S. Alpert, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, T. W. Davidson, J. L. Davis, P. S. Douglas, L. D. Gillam, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography Circulation, March 18, 1997; 95(6): 1686 - 1744. [Full Text]

				W. N. Irani, P. A. Grayburn, and I. Afridi Prevalence of Thrombus, Spontaneous Echo Contrast, and Atrial Stunning in Patients Undergoing Cardioversion of Atrial Flutter: A Prospective Study Using Transesophageal Echocardiography Circulation, February 18, 1997; 95(4): 962 - 966. [Abstract] [Full Text]

				R. E. Peverill, R. W. Harper, J. Gelman, T. E. Gan, G. Harris, and J. J. Smolich Determinants of Increased Regional Left Atrial Coagulation Activity in Patients With Mitral Stenosis Circulation, August 1, 1996; 94(3): 331 - 339. [Abstract] [Full Text]

				E. Leistad, G. Aksnes, E. Verburg, and G. Christensen Atrial Contractile Dysfunction After Short-term Atrial Fibrillation Is Reduced by Verapamil but Increased by BAY K8644 Circulation, May 1, 1996; 93(9): 1747 - 1754. [Abstract] [Full Text]

				B. D. Lindsay Obliteration of the Left Atrial Appendage: A Concept Worth Testing Ann. Thorac. Surg., February 1, 1996; 61(2): 515 - 515. [Full Text]

				J. L. Blackshear and J. A. Odell Appendage Obliteration to Reduce Stroke in Cardiac Surgical Patients With Atrial Fibrillation Ann. Thorac. Surg., February 1, 1996; 61(2): 755 - 759. [Abstract] [Full Text]

				D. Y. Leung, I. W. Black, G. B. Cranney, W. F. Walsh, R. A. Grimm, W. J. Stewart, and J. D. Thomas Selection of Patients for Transesophageal Echocardiography After Stroke and Systemic Embolic Events : Role of Transthoracic Echocardiography Stroke, October 1, 1995; 26(10): 1820 - 1824. [Abstract] [Full Text]